TrueBinding Stock

HealthTech

TrueBinding, a developer of antibody drugs, creates treatments intended for applications in immune-oncology and other disease areas. Their drugs provide novel ligands to receptors of documented checkpoint inhibitor pathways and an artificial intelligence and big data-driven platform. They offer services to their clients, including anti-cancer immunotherapy and targeted antibody drug delivery.